AfterRaise/Companies/Bioness Medical

Bioness Medical

$15M DebtRaised yesterdayValencia, USAHealthcare & MedtechUSA
Visit website →

Why now

Where Bioness Medical is today

Bioness Medical announced a funding round of $15M on 4 September 2026, led by Horizon Technology Finance Corporation.

Latest round
Debt
Amount
$15M
Announced
4 September 2026
Headquarters
Valencia, USA
Sector
Healthcare & Medtech
Growth stage
Growth
Investors
Horizon Technology Finance Corporation
Also participating
Not stated
Relevant leadership
CEO Todd Cushman

Momentum AfterRaise intelligence

AfterRaise Score

62
Building momentum
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
12/25
round size relative to the market
Funding stage
10/20
Debt
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

In their own words

What Bioness Medical says it is doing

Work here? Add to this

Public signal Described in the funding announcement as "provider of FDA-approved neurorehabilitation technologies designed to improve mobility and function for individuals recovering from stroke, spinal cord injury, and other neurological conditions". Source

Market expansionProductRegulatory

Public signal Read from the company's own description of what the funding supports.

Since the raise

What has happened since

  • 4 September 2026
    $15M Debt
    Led by Horizon Technology Finance Corporation.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What happens next

What this raise plausibly creates

AfterRaise inferenceAfterRaise intelligence

Likely next Moves

  • New market entry
  • First local hires in the new market
  • Local entity and legal setup
  • Product launches and new tiers

Opportunities this could create

  • Regulatory affairs
  • Quality systems
  • Clinical hiring
  • Provider partnerships
  • Market-entry advisers

Based on the Healthcare & Medtech sector, a Growth round and the priorities the company itself set out. Not a statement of fact.

High momentum4 connected signals
  • 4 September 2026$15M Debt announced
  • 4 September 2026Stated priority: market expansion
  • 4 September 2026Stated priority: product
  • 4 September 2026Stated priority: regulatory

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Bioness Medical is open to

Not yet specified

Bioness Medical has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Bioness Medical

No open Opportunities listed

Jobs, projects, partnerships and advisory needs appear here once the company has claimed its page and published them.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Work here?

Your company is growing. Tell people what you need next.

This page belongs to Bioness Medical. Claim it to say where you are going, correct anything AfterRaise got wrong, publish the work you have open, and choose who may approach you. Companies are more protected after claiming, not less: you decide what kinds of approach you want, and we refuse the rest.

What we do not have yet: the roles and projects you have open. Claiming the page is how you fill those in.

Also moving

Other Healthcare & Medtech companies

See the sector